Edit
Syndesi Therapeutics
http://www.syndesitherapeutics.com/Last activity: 12.02.2018
Active - Reference to AbbVie
Syndesi Therapeutics is developing novel modulators of the synaptic vesicle protein SV2A to address disorders of cognition.
Location: Belgium, Walloon Brabant, Ottignies-Louvain-la-Neuve
Employees: 11-50
Total raised: $20.83M
Founded date: 2018
Investors 2
| Date | Name | Website |
| - | UCB Ventur... | ucbventure... |
| - | V-Bio Vent... | v-bio.vent... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 09.02.2018 | Series A | $20.83M | - |
Mentions in press and media 2
| Date | Title | Description |
| 12.02.2018 | Term Sheet — Monday, February 12 | SETTLED Good morning, Term Sheet readers. Paid Content What you need to know about growing cyberattacks From ExtraHop Uber also agreed to refrain from using Waymo’s technology, along with ensuring no Waymo components were already in use. As... |
| 09.02.2018 | Syndesi Therapeutics Raises €17M in Series A Financing | Syndesi Therapeutics, a Belgian developer of a series of novel, procognitive SV2A modulators, raised €17M in Series A financing. The round was led by Novo Seeds and Fountain Healthcare together with Johnson & Johnson Innovation – JJDC, ... |